Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zekeriya Hannarici

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Journal of Clinical Densitometry : the Official Journal of the International Society for Clinical Densitometry|February 16, 2022
Evaluation of Clinical and Laboratory Factors Affecting Bone Mineral Density Measurements in Patients with Kidney TransplantZekeriya Hannarici, Rıfkı Uçler, Saliha Yıldız, et al.
Melanoma Research|September 27, 2021
A novel prognostic biomarker for cutaneous malignant melanoma: red cell distribution width (RDW) to lymphocyte ratioZekeriya Hannarici, Ali Yilmaz, Mehmet E Buyukbayram, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|February 24, 2022
Lipegfilgrastim may cause hyperleukocytosisZekeriya Hannarici, Ali Yılmaz, Mehmet Emin Buyukbayram, et al.
Future Oncology (London, England)|August 25, 2021
The importance of the glucose-to-lymphocyte ratio in patients with hepatocellular carcinoma treated with sorafenibAli Yılmaz, Melih Şimşek, Zekeriya Hannarici, et al.
Diagnostics (Basel, Switzerland)|December 30, 2025
Prognostic Value of the PILE Score in Esophageal Squamous Cell Carcinoma Treated with Neoadjuvant ChemoradiotherapyAykut Turhan, Mehmet Emin Büyükbayram, Zekeriya Hannarici, et al.
Future Oncology (London, England)|May 1, 2023
The value of pretreatment glucose-to-lymphocyte ratio for predicting survival of metastatic gastric cancerZekeriya Hannarici, Ali Yılmaz, Mehmet Emin Buyukbayram, et al.
Clinical Medicine Insights. Oncology|July 30, 2025
The Relationship Between Vitamin D and Euthyroid Sick Syndrome in Hospitalized Solid Cancer Patients: A Retrospective StudyMehmet Emin Buyukbayram, Zekeriya Hannarici, Aykut Turhan, et al.
Diagnostics (Basel, Switzerland)|June 26, 2026
Prognostic Value of the Gustave Roussy Immune Score in Patients with Locally Advanced Gastric Cancer Receiving Neoadjuvant FLOT Chemotherapy: A Retrospective Cohort StudyAykut Turhan, Mehmet Emin Büyükbayram, Zekeriya Hannarici, et al.
Journal of Clinical Medicine|June 26, 2026
Prognostic Value of the Objective Prognostic Score and Palliative Prognostic Index for Short-Term Mortality in Terminal Cancer Patients Receiving Best Supportive Care: A Prospective Observational Single-Center StudyAlperen Akansel Çağlar, Zekeriya Hannarici, Mehmet Emin Büyükbayram, et al.
BMC Cancer|May 23, 2024
A novel prognostic biomarker in progression free survival for patients with cervical cancer, glucose to c-reactive protein ratio (GCR)Mehmet Emin Buyukbayram, Zekeriya Hannarici, Aykut Turhan, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Journal of Clinical Densitometry : the Official Journal of the International Society for Clinical Densitometry|February 16, 2022
Evaluation of Clinical and Laboratory Factors Affecting Bone Mineral Density Measurements in Patients with Kidney TransplantZekeriya Hannarici, Rıfkı Uçler, Saliha Yıldız, et al.
Melanoma Research|September 27, 2021
A novel prognostic biomarker for cutaneous malignant melanoma: red cell distribution width (RDW) to lymphocyte ratioZekeriya Hannarici, Ali Yilmaz, Mehmet E Buyukbayram, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|February 24, 2022
Lipegfilgrastim may cause hyperleukocytosisZekeriya Hannarici, Ali Yılmaz, Mehmet Emin Buyukbayram, et al.
Future Oncology (London, England)|August 25, 2021
The importance of the glucose-to-lymphocyte ratio in patients with hepatocellular carcinoma treated with sorafenibAli Yılmaz, Melih Şimşek, Zekeriya Hannarici, et al.
Diagnostics (Basel, Switzerland)|December 30, 2025
Prognostic Value of the PILE Score in Esophageal Squamous Cell Carcinoma Treated with Neoadjuvant ChemoradiotherapyAykut Turhan, Mehmet Emin Büyükbayram, Zekeriya Hannarici, et al.
Future Oncology (London, England)|May 1, 2023
The value of pretreatment glucose-to-lymphocyte ratio for predicting survival of metastatic gastric cancerZekeriya Hannarici, Ali Yılmaz, Mehmet Emin Buyukbayram, et al.
Clinical Medicine Insights. Oncology|July 30, 2025
The Relationship Between Vitamin D and Euthyroid Sick Syndrome in Hospitalized Solid Cancer Patients: A Retrospective StudyMehmet Emin Buyukbayram, Zekeriya Hannarici, Aykut Turhan, et al.
Diagnostics (Basel, Switzerland)|June 26, 2026
Prognostic Value of the Gustave Roussy Immune Score in Patients with Locally Advanced Gastric Cancer Receiving Neoadjuvant FLOT Chemotherapy: A Retrospective Cohort StudyAykut Turhan, Mehmet Emin Büyükbayram, Zekeriya Hannarici, et al.
Journal of Clinical Medicine|June 26, 2026
Prognostic Value of the Objective Prognostic Score and Palliative Prognostic Index for Short-Term Mortality in Terminal Cancer Patients Receiving Best Supportive Care: A Prospective Observational Single-Center StudyAlperen Akansel Çağlar, Zekeriya Hannarici, Mehmet Emin Büyükbayram, et al.
BMC Cancer|May 23, 2024
A novel prognostic biomarker in progression free survival for patients with cervical cancer, glucose to c-reactive protein ratio (GCR)Mehmet Emin Buyukbayram, Zekeriya Hannarici, Aykut Turhan, et al.
Pageof 2